Cynata Therapeutics Ltd
About
Cynata Therapeutics Ltd is an Australian biotechnology company focused on developing and commercializing stem cell therapies. The company utilizes its proprietary Cymerus technology platform to produce mesenchymal stem cells (MSCs) for therapeutic use. Cynata's primary focus is on developing treatments for conditions such as graft-versus-host disease, osteoarthritis, and respiratory diseases. The company aims to advance its product candidates through clinical trials and establish partnerships for commercialization.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- CYP
Related Shares
Investor Resources
Should you buy Cynata Therapeutics Ltd right now?
While CYP looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now